You are here: Industry Insights > Cancer vaccines

News List

Ultimovacs Announces Review Article Highlighting Telomerase-based Therapeutic Cancer Vaccines firstwordpharma
July 06, 2021
Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, today announced the publication of a review of telomerase-based therapeutic cancer vaccines including the Company's universal cancer vaccine, UV1.
Vaccibody signs agreement with Genentech for individualised neoantigen cancer vaccines pharmaceutical-technology
October 10, 2020
Biopharmaceutical company Vaccibody has signed an exclusive worldwide license and collaboration agreement with Genentech for the development and commercialisation of DNA-based individualised neoantigen cancer vaccines.
Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines pharmaceutical-business-review
June 23, 2020
Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations.
Bayer invests in Khloris’ anti-cancer vaccines programme pharmaceutical-technology
April 23, 2019
Bayer invests in Khloris’ anti-cancer vaccines programme.
Leaps by Bayer, Khloris to develop breakthrough anti-cancer vaccines biospectrumasia
April 03, 2019
Leaps by Bayer, the investment arm of the global life sciences company Bayer, and Khloris Biosciences, a biotechnology company……
HPV vaccines continue to dominate cancer vaccines landscape pharmaceutical-technology
January 08, 2019
Cancer vaccines are a type of immunotherapy used to either treat existing cancer or prevent the development of cancer.
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S. fiercepharma
December 11, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the mission of bringing some novel...
First U.S.-Cuba biotech JV to bring Cuban-developed cancer vaccines to the U.S. fiercepharma
November 09, 2018
Three years after the U.S. and Cuba restored their diplomatic relations, the first biotech joint venture between institutions from the two countries has launched with the
Sri Lanka to register two foreign cancer vaccines biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.
Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility biospectrumasia
May 14, 2018
The custom buildout will be financed with proceeds from a recently completed $9 million secured convertible note financing...